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Abstract: We live in a world with the constant threat of emerg-
ing viral infections. In the last two decades, we have seen the
highly publicised emergence of the Nipah Virus, SARS, MERS, the
re-emergence of Ebola and the H1N1 2009 pandemic inﬂuenza
together with a host of other emerging and re-emerging viruses
includingZika, Chikungunya,Dengue. As clinicians,we are the front
line of response to these threats and the key to the response has to
be good surveillance and clinical management. High quality clin-
ical microbiology support is critical as is both “shoe-leather” and
molecular epidemiology. Only after the diagnosis has been clearly
establishedand theepidemiologyclariﬁed, canquality clinical trials
be considered for therapeutics and vaccines although the develop-
ment could begin as soon as a novel pathogen is identiﬁed.Wehave
learned many lessons from the responses both local and global to
these new viral threats. One important one is the role of risk com-
munication both among staff and the public. This is often ignored
at our own peril as the responses of the community often have a
disproportionate role in our work in controlling these infectious
threats. Despite the billions of dollars poured into the prevention
and control of these infections, most are without effective vaccines
or therapeutics. There are also a number of emerging issues in
pathogenesis and virulence which have yet to be answered. The
task ahead is daunting but with good international collaboration,
wehave the opportunity tomake a signiﬁcant difference in thenext
emerging viral threat while not ignoring the current smouldering
epidemics and endemic infections around us.
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Abstract: Intensive care units are often the focus of epidemics –
these include novel emerging pathogens as well as endemic multi-
resistantorganismsoreven less commonenvironmentalpathogens
or common hospital acquired infections. The reasons for this are
simple – patient in the intensive care units are vulnerable – many
are immunocompromised either by their underlying diseases or
because of the therapeutic agents used to treat their cancers or
rheumatological conditions. They also have numerous invasive
medical devices which can put them at risk of device associated
infections andmany outbreaks have been documented in intensive
care units all across the world from breaks in infection control in
themanagement of patientswith invasivemedical devices. In addi-
tion, many patients with severe acute emerging infections such as
SARS, MERS or novel strains of inﬂuenza will present to intensive
care units. These pose a challenge to intensivists and all the staff
in intensive care units who have to ensure that the best medical
care is provided to these patients without them becoming the foci
of outbreakswithin the intensive care units themselves. TheWorld
Health Organization’s Core Competencies for Infection Control are
a good starting point for developing our own guidelines for infec-
tion control in our intensive care units to ensure that epidemics
of infectious diseases are not allowed to spread in our ICUs and to
provide the best possible clinical outcomes for our patients.
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Abstract: The burden of sepsis is high in low andmiddle income
countries. This often results in a high mortality along with associ-
ated increase in hospital stay, morbidity and health-care related
expenses. High costs of medical care related to sepsis often lead to
termination of hospitalisation and discharge, apparently, against
medical advice in these countries, where cost of medical treatment
is usually borne by the individuals themselves. But those who can
afford medical care often prefer to stay much longer and complete
the entire treatment schedule in hospitals, as the infrastructure to
ensure continuity of medical care is lacking in society.
There is, however, little data available on the epidemiology
of sepsis in low and middle income countries. Studies are small
and observational, mainly from patients admitted to corporate
hospitals. These studies indicate that the burden of infections of
suspected sepsis are either undifferentiated acute febrile illnesses
related to tropical infections or gram negative infections related to
urosepsis, skin and soft tissue infections or pneumonia. Data from
prospective large scale studies are lacking.
One should also appreciate the fact that the epidemiology of
sepsis in low and middle income countries is closely intertwined
with the issue of antimicrobial resistance. Studies have also shown
that there is a correlation between the warmer temperatures and
the incidence of gram negative infections.
Finally, the problem of diagnosing sepsis and differentiating it
from systemic inﬂammatory response is a major challenge in the
developing world. Unless diagnostic modalities are improved, a
true picture of the epidemiology of sepsis will be a mirage.
http://dx.doi.org/10.1016/j.ijid.2016.02.184
